drugset / Trial / NCT01134055
Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of different dosage regimens of pazopanib eye drops for the treatment of neovascular age-related macular degeneration.
Timeline
- Start
- 2010-06-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pazopanib | Small molecule | 5 mg/ml | Other |
| Subject | Pazopanib | Small molecule | 10 mg/ml | Other |
| Comparator | Ranibizumab | Monoclonal antibody | — | Intravitreal |